Sign in

CIK 0001761918 · <br>Emerging growth company

Erasca, Inc.

Sign in to watch
Ticker
ERAS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831217027
Phone
(858) 465-6511
Business address
3115 MERRYFIELD ROW, THIRD FLOOR, SAN DIEGO, CA, 92121
  1. 4 Derivatives Options or other derivatives
  2. 4 Other acquisition Chief Financial Officer acquired 1,750 shares (other)
  3. 4 Other acquisition Chief Medical Officer acquired 1,750 shares (other)
  4. 4 Other acquisition General Counsel & Corp. Sec. acquired 2,390 shares (other)
  5. 4 Open-market buy Chairman & CEO bought 60,000 shares at $3.86 ($231,420)
  6. 4 Open-market buy Director bought 10,000 shares at $4.64 ($46,400)
  7. 4 Open-market buy Director bought 20,000 shares at $4.14 ($82,800)
  8. 4/A Open-market buy Director bought 307,692 shares at $6.50 ($1,999,998)
  9. 4 Open-market buy Director bought 307,692 shares at $6.50 ($1,999,998)
  10. 4 Open-market buy Director bought 20,000 shares at $4.87 ($97,490)
  11. 4 Open-market buy Chairman & CEO bought 40,000 shares at $4.99 ($199,600)
  12. 4 Other disposition Director disposed of 750,000 shares (other)
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 7 · 127 filings